Symrise AG (SY1):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Symrise AG (SY1) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9928
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Symrise AG (Symrise) offers flavors and fragrances. The company develops, produces and sells flavorings, fragrances, cosmetic active ingredients and raw materials, and functional ingredients and solutions for the cosmetics industry. It also provides biofunctional and bioactive ingredients and substances to the health and personal care sector. Symrise produces its products mainly on the basis of natural raw materials like vanilla, citrus fruits, onions, fish, meat, blossoms and plant materials. The company’s customers include companies in the perfume, cosmetics, food, pharma and nutritional supplements industries, and manufacturers of household products. It has operational presence in Europe, Africa, the Middle East, Asia Pacific, North America and Latin America. The company is headquartered in Holzminden, Germany.

Symrise AG (SY1) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Symrise AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Symrise AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Symrise AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Symrise AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Symrise AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Symrise AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Symrise Enters Into R&D Agreement With Probi For Probiotic Products 10
Licensing Agreements 11
Symrise Enters Into Licensing Agreement With Ceapro 11
Acquisition 12
Symrise Completes Acquisition Of Additional 3.53% Stake In Probi 12
Symrise AG – Key Competitors 13
Symrise AG – Key Employees 14
Symrise AG – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Symrise AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Symrise AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Symrise AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Symrise AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Symrise AG, Deals By Therapy Area, 2012 to YTD 2018 8
Symrise AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Symrise Enters Into R&D Agreement With Probi For Probiotic Products 10
Symrise Enters Into Licensing Agreement With Ceapro 11
Symrise Completes Acquisition Of Additional 3.53% Stake In Probi 12
Symrise AG, Key Competitors 13
Symrise AG, Key Employees 14
Symrise AG, Subsidiaries 15

List of Figures
Symrise AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Symrise AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Symrise AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Symrise AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Symrise AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Symrise AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Symrise AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Symrise AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Symrise AG (SY1):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Blue Earth Inc:電力:M&Aディール及び事業提携情報
    Summary Blue Earth Inc (Blue Earth), formerly Genesis Fluid Solutions Holdings Inc is a renewable energy solutions provider. The company's services include energy efficiency solutions, alternative energy solutions, renewable energy solutions, acquisition, alternative and renewable energy plants fina …
  • Frontken Corporation Berhad (FRONTKN):企業の財務・戦略的SWOT分析
    Summary Frontken Corporation Berhad (Frontken) is a construction and industrial equipment provider. The company’s products include valves, motors, generators, pumps, transformers, turbines, compressors, diesel engines, steel rolls and boiler tubes. It offers services including thermal spray coating, …
  • Lutron Electronics Co Inc:企業の戦略的SWOT分析
    Lutron Electronics Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development:製薬・医療:M&Aディール及び事業提携情報
    Summary Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a subsidiary of National Institutes of Health, is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the …
  • Academic Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Academic Medical Center (AMC), a subsidiary of University of Amsterdam is a medical center that offers research and educational services. The center offers services such as medical research, treatment of patients, and medical education services, among others. It provides its medical treatmen …
  • BAE Systems Inc:企業の戦略・SWOT・財務情報
    BAE Systems Inc - Strategy, SWOT and Corporate Finance Report Summary BAE Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Edgewell Personal Care LLC (EPC):企業の財務・戦略的SWOT分析
    Edgewell Personal Care LLC (EPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Saniona AB (SANION):企業の財務・戦略的SWOT分析
    Summary Saniona AB (Saniona) formerly Aniona, is a research and development company that develops drugs for central nervous system diseases, autoimmune diseases, metabolic diseases and pain management. The company’s pipeline products include tesofensine, a triple monoamine reuptake inhibitor, which …
  • Ted Baker PLC (TED):企業の財務・戦略的SWOT分析
    Ted Baker PLC (TED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nippon Sheet Glass Co Ltd:戦略・SWOT・企業財務分析
    Nippon Sheet Glass Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Sheet Glass Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Naspers Limited:企業のM&A・事業提携・投資動向
    Naspers Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Naspers Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Celulose Nipo-Brasileira SA:企業の戦略的SWOT分析
    Celulose Nipo-Brasileira SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • NRG Energy Inc (NRG):企業の財務・戦略的SWOT分析
    NRG Energy Inc (NRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • American Financial Group, Inc.:企業の戦略・SWOT・財務情報
    American Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Hornbeck Offshore Services, Inc. (HOS)-石油・ガス分野:企業M&A・提携分析
    Summary Hornbeck Offshore Services, Inc. (HOS) is a provider of marine services. The company offers marine transportation, subsea installation and accommodation support services to exploration and production, oilfield service, offshore construction and the US military customers. It supplies vessels, …
  • Steel Authority of India Ltd:企業の戦略・SWOT・財務情報
    Steel Authority of India Ltd - Strategy, SWOT and Corporate Finance Report Summary Steel Authority of India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • A. O. Smith Corporation (AOS):企業の財務・戦略的SWOT分析
    A. O. Smith Corporation (AOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Galliford Try Plc (GFRD):企業の財務・戦略的SWOT分析
    Galliford Try Plc (GFRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hitachi Capital (UK) PLC:企業の戦略・SWOT・財務情報
    Hitachi Capital (UK) PLC - Strategy, SWOT and Corporate Finance Report Summary Hitachi Capital (UK) PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆